Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Ossenkoppele

Showing results (201-210 of 295) with videos related to

Pageof 30
Sort By:
European Radiology|April 23, 2015
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?Sander C J Verfaillie, Sofie M Adriaanse, Maja A A Binnewijzend, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in femalesCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Molecular Neurodegeneration|March 18, 2025
Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer's diseaseNicolai Franzmeier, Sebastian Niclas Roemer-Cassiano, Alexander Maximilian Bernhardt, et al.
Neurology|April 22, 2014
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functionsRik Ossenkoppele, Wiesje M van der Flier, Sander C J Verfaillie, et al.
Neurology|January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAnna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2022
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease ContinuumEmma M Coomans, Inge M W Verberk, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical dataLinda Karlsson, Jacob Vogel, Ida Arvidsson, et al.
JAMA Neurology|May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer DiseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Journal of Neurology|July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onsetDaniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Frontiers in Aging Neuroscience|February 15, 2019
Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe ProjectSander C J Verfaillie, Tessa Timmers, Rosalinde E R Slot, et al.
Pageof 30

Showing results (201-210 of 295) with videos related to

Sort By:
Pageof 30
European Radiology|April 23, 2015
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?Sander C J Verfaillie, Sofie M Adriaanse, Maja A A Binnewijzend, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 26, 2026
Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in femalesCarling G Robinson, Alexa Pichet Binette, Kanta Horie, et al.
Molecular Neurodegeneration|March 18, 2025
Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer's diseaseNicolai Franzmeier, Sebastian Niclas Roemer-Cassiano, Alexander Maximilian Bernhardt, et al.
Neurology|April 22, 2014
Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functionsRik Ossenkoppele, Wiesje M van der Flier, Sander C J Verfaillie, et al.
Neurology|January 9, 2015
Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progressionAnna Caroli, Annapaola Prestia, Samantha Galluzzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 13, 2022
A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer's Disease ContinuumEmma M Coomans, Inge M W Verberk, Rik Ossenkoppele, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 22, 2025
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical dataLinda Karlsson, Jacob Vogel, Ida Arvidsson, et al.
JAMA Neurology|May 26, 2026
Plasma eMTBR-tau243 and %p-tau217 for Biological Staging of Alzheimer DiseaseGemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Journal of Neurology|July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onsetDaniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Frontiers in Aging Neuroscience|February 15, 2019
Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe ProjectSander C J Verfaillie, Tessa Timmers, Rosalinde E R Slot, et al.
Pageof 30